Remotely Monitored Therapy and Nitric Oxide Suppression Identifies Nonadherence in Severe Asthma.

Liam G HeaneyJohn BusbyPeter BraddingRekha ChaudhuriAdel H MansurRobert NivenIan D PavordJohn T LindsayRichard W Costellonull null

Published in: American journal of respiratory and critical care medicine (2020)

Remote FeNO suppression testing is an effective means of identifying nonadherence to ICS in subjects with difficult-to-control asthma and the substantial population of subjects who derive important clinical benefits from optimized ICS/long-acting β2-agonist treatment.

Keyphrases

nitric oxide
chronic obstructive pulmonary disease
lung function
hydrogen peroxide
nitric oxide synthase
allergic rhinitis
mesenchymal stem cells
air pollution